Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CardioSenseSystem Compared to Philips Telemetry System Regarding Efficacy and Safety in the Monitoring of ECG

NCT03610529 is registered in ClinicalTrials.gov with Novosense AB as lead sponsor.

NCT NCT03610529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03610529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CardioSenseSystem Compared to Philips Telemetry System Regarding Efficacy and Safety in the Monitoring of ECG
Lead sponsor
Novosense AB
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2020
Completion date
December 30, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrythmias, disorder of aorta, heart valve disorders, unstable angina